U.S. pressures Germany to raise drug prices due to "pharmaceutical innovation"
[91736] U.S. pressures Germany to raise drug prices due to "pharmaceutical innovation"
Reports of heavy American pressure on the German government to raise drug prices in the country in the name of encouraging global research and development.
Diplomatic tensions over drug prices in Germany
According to a report by pubity, the U.S. administration has opened an inquiry with Germany regarding its healthcare policy, which allows for high accessibility to drugs at affordable prices. According to the source, the U.S. is pressuring Berlin to raise consumer drug prices.
The central argument of the American side, as reported in pubity, is that low drug prices in Germany harm incentives for "innovative pharmaceutical research." Washington fears that the lack of price increases in Germany prevents controlled global price decreases and weakens investments in the sector.
As of now, this is an American initiative intended to influence Germany's internal policy in the field of welfare and public health, while demanding changes to the economic structure of the local pharmaceutical market to align it with the international economic standards of the pharma industry.